Skip to main content

Table 2 Univariate and multivariate analyses of factors associated with OS in the training cohort

From: Development and validation of prognostic nomograms for patients with colon neuroendocrine neoplasms

Variable

Univariate analysis

Multivariate analysis

 

HR (95% CI)

P value

HR (95% CI)

P value

Age, years

 0–55

Reference

 

Reference

 

 56–67

1.6 (1.2, 2.0)

0.001

1.2 (0.9, 1.6)

0.206

  ≥ 68

2.7 (2.1, 3.5)

0.001

1.7 (1.3, 2.2)

 < 0.001

Sex

 Female

Reference

 

Reference

 

 Male

1.1 (0.9, 1.3)

0.336

1.3 (1.1, 1.6)

0.005

Tumor size, mm

  < 35

Reference

 

Reference

 

  ≥ 35

4.3 (3.4, 5.4)

 < 0.001

1.5 (1.2, 2.0)

0.002

Laterality

 Right

Reference

 

Reference

 

 Left

1.1 (0.8, 1.3)

0.663

1.2 (1.0, 1.6)

0.077

Grade

 G1

Reference

 

1

 

 G2

2.0 (1.3, 2.9)

 < 0.001

1.5 (1.0, 2.2)

0.066

 G3

8.8 (6.6, 11.7)

 < 0.001

4.8 (3.3, 6.9)

 < 0.001

 G4

10.8 (7.8, 15.0)

 < 0.001

5.2 (3.5, 7.8)

 < 0.001

Pathology

 8013/3 large cell neuroendocrine carcinoma

Reference

 

Reference

 

 8041/3 small cell carcinoma

1.8 (1.2, 2.9)

0.006

1.5 (0.9, 2.4)

0.091

 8240/3 carcinoid tumor

0.1 (0.1, 0.2)

 < 0.001

0.7 (0.5, 1.1)

0.173

 8244/3 mixed adeno-neuroendocrine carcinoma

0.8 (0.5, 1.4)

0.472

1.5 (0.9, 2.5)

0.158

 8246/3 neuroendocrine carcinoma

0.7 (0.5, 0.9)

0.009

1.3 (1.0, 1.8)

0.094

Operation

 No operation

Reference

 

Reference

 

 Local tumor excision

0.0 (0.0, 0.1)

 < 0.001

0.3 (0.1, 1.1)

0.066

 Curative

0.5 (0.4, 0.8)

0.005

0.7 (0.5, 1.2)

0.181

Chemotherapy

 No

Reference

 

Reference

 

 Yes

3.2 (2.6, 3.8)

 < 0.001

0.8 (0.6, 1.0)

0.029

AJCC TNM stage (8th)

 I

Reference

   

 IIA

2.5 (0.9, 7.3)

0.095

  

 IIB

2.2 (0.9, 4.9)

0.068

  

 IIIA

6.0 (2.2, 16.6)

 < 0.001

  

 IIIB

4.4 (2.3, 8.4)

 < 0.001

  

 IV

15.6 (8.3, 29.4)

 < 0.001

  

AJCC T stage (8th)

 T1

Reference

 

Reference

 

 T1a

0.1 (0.0, 0.2) < 0.001

 < 0.001

1.7 (0.5, 5.5)

0.387

 T1b

0.1 (0.0, 0.2) < 0.001

 < 0.001

0.4 (0.1, 1.8)

0.248

 T2

0.2 (0.1, 0.4) < 0.001

 < 0.001

0.7 (0.3, 2.1)

0.575

 T3

0.3 (0.1, 0.8)

0.012

0.9 (0.3, 2.3)

0.776

 T4

0.5 (0.2, 1.1)

0.093

0.9 (0.3, 2.3)

0.827

AJCC N stage (8th)

 N0

Reference

 

Reference

 

 N1

2.5 (1.9, 3.3)

 < 0.001

1.9 (1.4, 2.6)

 < 0.001

AJCC M stage (8th)

 M0

Reference

 

Reference

 

 M1

4.5 (3.7, 5.5)

 < 0.001

3.5 (2.8, 4.4)

 < 0.001

  1. Abbreviations: AJCC American Joint Committee on Cancer, TNM tumor–node–metastasis, HR hazard ratio, CI confidence interval